Key facts
- It has raised $11.6M; the latest was Later Stage VC in Mar 2026.
- Notable investors include Suzhou Oriza Holdings Corporation, SND Ventures Group, 5Y Capital, Linear Capital, Sinochem Capital — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Hours (Discovery Tools)
- ·The full record, as it builds
Funding rounds
No funding rounds for Hours (Discovery Tools) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hours (Discovery Tools)
Developer of an AI decision-making platform intended for drug discovery and chemical synthesis. The company offers a platform that integrates different technologies and disciplines to model complicated drug discovery and production processes, thereby enabling scientists to leverage artificial intelligence to comprehend chemical reaction mechanisms in the laboratory quickly.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2018
- Website
- hourstec.com/
- Ownership
- Privately Held (backing)
Hours (Discovery Tools) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hours (Discovery Tools) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hours (Discovery Tools) in its N-PORT filings yet. We sweep new filings monthly.